Rocket Pharmaceuticals (RCKT) Amortization of Deferred Charges (2014 - 2017)
Rocket Pharmaceuticals (RCKT) reported Amortization of Deferred Charges of $151000.0 for Q4 2017, up 7.86% on a YoY basis from $140000.0 in Q4 2016, and up 2.03% sequentially from $148000.0 in Q3 2017.
Rocket Pharmaceuticals (RCKT) Amortization of Deferred Charges (2014 - 2017) Analysis & Trends
Rocket Pharmaceuticals (RCKT) has 4 years of Amortization of Deferred Charges data on file, last reported at $151000.0 in Q4 2017.
- For the quarter ending Q4 2017, Amortization of Deferred Charges rose 7.86% year-over-year to $151000.0; the trailing twelve-month figure through Dec 2017 stood at $581000.0 (down 41.78% YoY), and the FY2017 full-year result was $581000.0, up 161.71% from the prior year.
- Amortization of Deferred Charges rose to $151000.0 in Q4 2017, from $148000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $555000.0 in Q3 2015 to a low of $59000.0 in Q3 2014.
- A 4-year average of $198500.0 and a median of $145500.0 in 2017 frame the typical range for Amortization of Deferred Charges.
- Across the five-year window, Amortization of Deferred Charges soared 840.68% in 2015 and gained 7.86% in 2017, its largest moves.
- Tracing RCKT's Amortization of Deferred Charges over 4 years: stood at $73000.0 in 2014, then surged by 660.27% to $555000.0 in 2015, then sank by 74.77% to $140000.0 in 2016, then increased by 7.86% to $151000.0 in 2017.
- Business Quant data shows RCKT's Amortization of Deferred Charges at $151000.0 in Q4 2017, $148000.0 in Q3 2017, and $143000.0 in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,831.58 Bn | 66,831.30 Bn | - |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - |
| 3 | Akari Therapeutics | 976.78 Bn | 976.78 Bn | - |
| 4 | BeOne Medicines | 471.48 Bn | 466.69 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.78 Bn | 114.53 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.54 Bn | 34.53 Bn | 959.66 Mn |
| 10 | Rocket Pharmaceuticals | 370.04 Mn | 370.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 151,000.00 |
| Dec 31, 2017 | 151,000.00 |
| Sep 30, 2017 | 148,000.00 |
| Sep 30, 2017 | 148,000.00 |
| Jun 30, 2017 | 143,000.00 |
| Jun 30, 2017 | 143,000.00 |
| Mar 31, 2017 | 139,000.00 |
| Mar 31, 2017 | 139,000.00 |
| Dec 31, 2016 | 140,000.00 |
| Dec 31, 2016 | 140,000.00 |
| Sep 30, 2015 | 555,000.00 |
| Sep 30, 2015 | 555,000.00 |
| Jun 30, 2015 | 303,000.00 |
| Jun 30, 2015 | 303,000.00 |
| Mar 31, 2015 | 274,000.00 |
| Mar 31, 2015 | 274,000.00 |
| Dec 31, 2014 | 73,000.00 |
| Dec 31, 2014 | 73,000.00 |
| Sep 30, 2014 | 59,000.00 |
| Sep 30, 2014 | 59,000.00 |